Identification of type II toxin-antitoxin modules in Burkholderia pseudomallei

FEMS Microbiology Letters

Volumn 338, Issue 1, 2013, Pages 86-94

  Butt, Aaron ^a   Müller, Claudia ^a   Harmer, Nicholas ^a   Titball, Richard W ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Antibiotic resistance; Burkholderia pseudomallei; Expression and screening system; Melioidosis; Persister cell; Toxin antitoxin

Indexed keywords

BACTERIAL TOXIN; HICA PROTEIN; HIPA PROTEIN; RELE1 PROTEIN; RELE2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM CULTURE; BIOINFORMATICS; BURKHOLDERIA PSEUDOMALLEI; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; GENE EXPRESSION; GENOMIC ISLAND; GROWTH INHIBITION; HICA GENE; HIPA GENE; NONHUMAN; PRIORITY JOURNAL; RELB2 GENE; RELE2 GENE; TYPE II TOXIN ANTOXIN SYSTEM;

ANTITOXINS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BURKHOLDERIA PSEUDOMALLEI; COMPUTATIONAL BIOLOGY; CULTURE MEDIA; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; HUMANS;

BURKHOLDERIA PSEUDOMALLEI; ESCHERICHIA COLI;

EID: 84870947782     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/1574-6968.12032     Document Type: Article

References (33)

1. Amitai S, Yassin Y & Engelberg-Kulka H (2004) MazF-mediated cell death in Escherichia coli: a point of no return. J Bacteriol 186: 8295-8300.
2. Budde P, Davis B, Yuan J & Waldor M (2006) Characterization of a higBA toxin-antitoxin locus in Vibrio cholerae. J Bacteriol 189: 491-500.
3. Currie B, Fisher D, Anstey N & Jacups S (2000) Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 94: 301-304.
4. Daines D, Wu M & Yuan S (2007) VapC-1 of nontypeable Haemophilus influenzae is a ribonuclease. J Bacteriol 189: 5041-5048.
5. Datsenko K & Wanner B (2000) One step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. P Natl Acad Sci USA 97: 6640-6645.
6. Dörr T, Vulić M & Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8: e1000317.
7. Fauvart M, De Groote V & Michiels J (2011) Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol 60: 699-709.
8. Goulard C, Langrand S, Carniel E & Chauvaux S (2010) The Yersinia pestis chromosome encodes active addiction toxins. J Bacteriol 192: 3669-3677.
9. Jorgensen M, Pandey D, Jaskola M & Gerdes K (2008) HicA of Escherichia coli defines a novel family of translation-independent mRNA interferases in bacteria and archaea. J Bacteriol 191: 1191-1199.
10. Keren I, Kaldalu N, Spoering A & Lewis K (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230: 13-18.
11. Kolodkin-Gal I & Engelberg-Kulka H (2008) The extracellular death factor: physiological and genetic factors influencing tts production and response in Escherichia coli. J Bacteriol 190: 3169-3175.
12. Kolodkin-Gal I, Hazan R, Gaathon A, Carmeli S & Engelberg-Kulka H (2007) A linear pentapeptide is a quorum- sensing factor required for mazEF mediated cell death in Escherichia coli. Science 318: 652-658.
13. Korch S & Hill T (2006) Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol 188: 3826-3836.
14. Korch S, Henderson T & Hill T (2003) Characterisation of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 50: 1199-1213.
15. Lafleur M, Qi Q & Lewis K (2010) Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antmicrob Agents Chemother 54: 39-44.
16. Leung V & Lévesque C (2012) A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol 194: 2265-2274.
17. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357-372.
18. Maisonneuve E, Shakespeare L, Jorgensen M & Gerdes K (2011) Bacterial persistence by RNA endonucleases. P Natl Acad Sci USA 108: 13206-13211.
19. Makarova K, Wolf Y & Koonin E (2009) Comprehensive comparative-genomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol Direct 4: 19.
20. Moyed H & Bertrand K (1983) hipA, a newly recognised gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 166: 399-403.
21. Mulcahy L, Burns J, Lory S & Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192: 6191-6199.
22. Mutschler H, Gebhardt M, Shoeman R & Meinhart A (2011) A novel mechanism of programmed cell death in bacteria by toxin-antitoxin systems corrupts peptidoglycan synthesis. PLoS Biol 9: e1001033.
23. Pedersen K, Christensen S & Gerdes K (2002) Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol Microbiol 45: 501-510.
24. Rotem E, Loinger A, Ronin I, Levin-Reisman I, Gabay C, Shoresh N, Biham O & Balaban NQ (2010) Regulation of phenotypic variability by a threshold based mechanism underlies bacterial persistence. P Natl Acad Sci USA 107: 12541-12546.
25. Schumacher M, Piro K, Xu W, Hansen S, Lewis K & Brennan R (2009) Molecular mechanisms if HipA -mediated multidrug tolerance and its neutralisation by HipB. Science 323: 396-401.
26. Sevin E & Barloy-Hubler F (2007) RASTA-bacteria: A web based tool for identifying toxin-antitoxin loci in prokaryotes. Genome Biol 8: R155.
27. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K & Lewis K (2006) Persisters: a distinct physiological state of E. coli. BMC Microbiol 6: 53.
28. Shao Y, Harrison E, D B, X H, Ou H, Rajakumar K & Deng Z (2011) TADB: a web-based resource for Type 2 toxin-antitoxin loci in bacteria and archaea. Nucleic Acids Res 39: D606-D611.
29. Sim S, Yu Y, Lin C et al. (2008) The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis. PLoS Pathog 10: e1000178.
30. Tashiro Y, Kawata K, Taniuchi A, Kakinuma K, May T & Okabe S (2012) RelE-mediated dormancy is enhanced at high cell density in Escherichia coli. J Bacteriol 194: 1169-1176.
31. Tsilibaris V, Maenhaut-Michel G, Mine N & Melderen L (2007) What is the benefit to Escherichia coli is having multiple toxin-antitoxin in its genome? J Bacteriol 189: 6101-6108.
32. Yamaguchi Y & Inouye M (2011) Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. Nat Rev Microbiol 9: 779-790.
33. Yamaguchi Y, Park J & Inouye M (2011) Toxin-antitoxin systems in Bacteria and Archaea. Annu Rev Genet 45: 61-79.